Ascentage Pharma Announces Series B Financing of RMB 500 Million to Advance Its Apoptosis-Targeted...

Ascentage Pharma, a global, clinical-stage biopharmaceutical company focused on apoptosis-targeted oncology drug discovery and development, has announced the completion of its Series B financing of RMB 500 million (equal to approximately $72...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Expands Site in the United States for Drug Development...

We are pleased to announce the grand opening of WuXi AppTec's expanded Laboratory Testing Division (LTD) facility in New Jersey. The expansion will double total...